Clinical Trial Active Learning
This paper presents a novel approach to active learning that takes into account the non-independent and identically distributed (non-i.i.d.) structure of a clinical trial setting. There exists two types of clinical trials: retrospective and prospective. Retrospective clinical trials analyze data after treatment has been performed; prospective clinical trials collect data as treatment is ongoing. Typically, active learning approaches assume the dataset is i.i.d. when selecting training samples; however, in the case of clinical trials, treatment results in a dependency between the data collected at the current and past visits. Thus, we propose prospective active learning to overcome the limitations present in traditional active learning methods and apply it to disease detection in optical coherence tomography (OCT) images, where we condition on the time an image was collected to enforce the i.i.d. assumption. We compare our proposed method to the traditional active learning paradigm, which we refer to as retrospective in nature. We demonstrate that prospective active learning outperforms retrospective active learning in two different types of test settings.
Code (1)
Tasks
Active LearningSimilar Papers 제목 키워드 기반
ClinicalTrialsHub: Bridging Registries and Literature for Comprehensive Clinical Trial Access
We present ClinicalTrialsHub, an interactive search-focused platform that consolidates all data from ClinicalTrials.gov and augments it by automatically extracting and structuring trial-relevant information from PubMed r…
Information ExtractionQuestion AnsweringROBoto2: An Interactive System and Dataset for LLM-assisted Clinical Trial Risk of Bias Assessment
We present ROBOTO2, an open-source, web-based platform for large language model (LLM)-assisted risk of bias (ROB) assessment of clinical trials. ROBOTO2 streamlines the traditionally labor-intensive ROB v2 (ROB2) annotat…
Efficient adaptive designs for clinical trials of interventions for COVID-19
The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therap…
Towards Regulatory-Confirmed Adaptive Clinical Trials: Machine Learning Opportunities and Solutions
Randomized Controlled Trials (RCTs) are the gold standard for evaluating the effect of new medical treatments. Treatments must pass stringent regulatory conditions in order to be approved for widespread use, yet even aft…
Active LearningEarly Risk Stratification of Dosing Errors in Clinical Trials Using Machine Learning
Objective: The objective of this study is to develop a machine learning (ML)-based framework for early risk stratification of clinical trials (CTs) according to their likelihood of exhibiting a high rate of dosing errors…